Entropy Neurodynamics Limited (ASX:ENP)
Australia · Delayed Price · Currency is AUD 0.0370
+0.0010 (2.78%)
At close: Feb 19, 2026
Entropy Neurodynamics Market Cap
Entropy Neurodynamics has a market cap or net worth of 59.72 million as of February 19, 2026. Its market cap has increased by 26.44% in one year.
Market Cap
59.72M
Enterprise Value
56.69M
Revenue
1.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since May 29, 2024, Entropy Neurodynamics's market cap has increased from 38.06M to 59.72M, an increase of 56.89%. That is a compound annual growth rate of 29.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 58.10M | 9.39% |
| Dec 31, 2025 | 53.11M | 9.50% |
| Dec 31, 2024 | 48.50M | 27.43% |
| May 29, 2024 | 38.06M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LTR Pharma | 94.52M |
| Alterity Therapeutics | 92.44M |
| Cynata Therapeutics | 89.45M |
| Imugene | 81.99M |
| EZZ Life Science Holdings | 76.21M |
| Radiopharm Theranostics | 74.43M |
| Prescient Therapeutics | 67.30M |
| Proteomics International Laboratories | 66.07M |